Abstract
Bidirectional exchange of cells between mother and fetus establishes microchimerism (Mc). Mc can persist for decades and is associated with later-life health and disease. Greater fetal Mc is detected in the maternal compartment in preeclampsia (PE), but whether maternal Mc (MMC) in umbilical cord blood (CB) is altered in PE is unknown. We evaluated MMc in CB from normal and PE pregnancies. DNA from CB mononuclear cells following placental delivery (n = 36 PE, n = 37 controls) and maternal blood was extracted and genotyped. MMc, quantified by qPCR assays targeting maternal-specific nonshared polymorphisms in CB, was compared using logistic and negative binomial regression models. Clinically and statistically relevant confounders were included, and included the total number of cell equivalents tested, gravidity, mode of delivery, birthweight, and fetal sex. PE participants delivered at earlier gestational ages, with higher Cesarean rates, and lower infant birthweights. CB MMc detection was similar between PE and controls (52.8% vs. 51.3%, respectively, p = 0.90) and unchanged after adjustment for confounders. MMc concentration was not different between groups (mean 73.7 gEq/105 gEq in PE vs. mean 22.8 gEq/105 in controls, p = 0.56), including after controlling for confounders (p = 0.64). There was no difference in CB MMc detection or concentration between PE and normal pregnancies, despite previously noted greater fetal Mc in the maternal compartment. This suggests possible differential transfer of cells at the maternal fetal interface in PE. Phenotypic evaluation of Mc cells may uncover underlying mechanisms for differential cellular exchange between mother and fetus in PE.
Similar content being viewed by others
References
Lo YM, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood. 1996;88(11):4390–5.
Adams Waldorf KM, et al. Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy. Placenta. 2010;31(7):589–94. https://doi.org/10.1016/j.placenta.2010.04.013.
Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol. 2012;33(8):421–7. https://doi.org/10.1016/j.it.2012.03.002.
Gammill HS, Harrington WE. Microchimerism: defining and redefining the prepregnancy context — a review. Placenta. 2017;60:130–3. https://doi.org/10.1016/j.placenta.2017.08.071.
Chen C-P, et al. Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells. 2008;26(2):550–61. https://doi.org/10.1634/stemcells.2007-0406.
Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, Bean MA. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood. 1995;86(7):2829–32.
Petit T, Dommergues M, Socié G, Dumez Y, Gluckman E, Brison O. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol. 1997;98(3):767–71.
Jonsson AM, Uzunel M, Götherström C, Papadogiannakis N, Westgren M. Maternal microchimerism in human fetal tissues. Am J Obstet Gynecol. 2008;198(3):325.e1-6. https://doi.org/10.1016/j.ajog.2007.09.047.
Mold JE, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008;322(5907):1562–5. https://doi.org/10.1126/science.1164511.
Dutta P, et al. Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood. 2009;114(17):3578–87. https://doi.org/10.1182/blood-2009-03-213561.
Buxmann H, et al. Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean section. Early Hum Dev. 2016;98:49–55. https://doi.org/10.1016/j.earlhumdev.2016.06.004.
Tapia G, et al. Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes. Pediatr Diabetes. 2019;20(6):728–35. https://doi.org/10.1111/pedi.12875.
Tapia G, et al. Maternal microchimerism in cord blood and risk of celiac disease in childhood. J Pediatr Gastroenterol Nutr. 2020;71(3):321–7. https://doi.org/10.1097/MPG.0000000000002811.
Opstelten R, et al. Determining the extent of maternal-foetal chimerism in cord blood. Sci Rep. 2019;9(1):5247. https://doi.org/10.1038/s41598-019-41733-w.
Kanold AMJ, Westgren M, Götherström C. Cellular subsets of maternal microchimerism in umbilical cord blood. Cell Transplant. 2019;28(5):522–8. https://doi.org/10.1177/0963689718779783.
Haddad ME, et al. Factors predicting the presence of maternal cells in cord blood and associated changes in immune cell composition. Front Immunol. 2021;12:651399. https://doi.org/10.3389/fimmu.2021.651399.
Kanaan SB, et al. Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant. Oncoimmunology. 2017;6(5):e1311436. https://doi.org/10.1080/2162402X.2017.1311436.
Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 2012;490(7418):102–6. https://doi.org/10.1038/nature11462.
Santner-Nanan B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183(11):7023–30. https://doi.org/10.4049/jimmunol.0901154.
Stevens AM, Hermes HM, Kiefer MM, Rutledge JC, Nelson JL. Chimeric maternal cells with tissue-specific antigen expression and morphology are common in infant tissues. Pediatr Dev Pathol. 2009;12(5):337–46. https://doi.org/10.2350/08-07-0499.1.
Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW. Maternal cell microchimerism in newborn tissues. J Pediatr. 2003;142(1):31–5. https://doi.org/10.1067/mpd.2003.mpd0327.
Peterson SE, et al. Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination. Hum Reprod. 2012;27(9):2607–12. https://doi.org/10.1093/humrep/des244.
Shree R, et al. Fetal microchimerism by mode of delivery: a prospective cohort study. BJOG. 2019;126(1):24–31. https://doi.org/10.1111/1471-0528.15432.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–74. https://doi.org/10.1016/S0140-6736(06)68397-9.
Shih T, et al. The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol. 2016;33(4):329–38. https://doi.org/10.1055/s-0035-1564881.
Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ. Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011;2011. https://doi.org/10.1155/2011/214365
Yıldırım G, Güngördük K, Aslan H, Gül A, Bayraktar M, Ceylan Y. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. J Turk Ger Gynecol Assoc. 2011;12(2):90–6. https://doi.org/10.5152/jtgga.2011.22.
Gammill HS, Aydelotte TM, Guthrie KA, Nkwopara EC, Nelson JL. Cellular fetal microchimerism in preeclampsia. Hypertension. 2013;62(6):1062–7.
Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O’Reilly RJ. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982;307(11):662–6. https://doi.org/10.1056/NEJM198209093071106.
Maloney S, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest. 1999;104(1):41–7. https://doi.org/10.1172/JCI6611.
Lu HQ, Hu R. Lasting effects of intrauterine exposure to preeclampsia on offspring and the underlying mechanism. AJP Rep. 2019;9(3):e275–91. https://doi.org/10.1055/s-0039-1695004.
Gestational hypertension and preeclampsia: ACOG practice bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237. https://doi.org/10.1097/AOG.0000000000003891.
Gammill HS, Stephenson MD, Aydelotte TM, Nelson JL. Microchimerism in recurrent miscarriage. Cell Mol Immunol. 2014;11(6):589–94. https://doi.org/10.1038/cmi.2014.82.
Lambert NC, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum. 2004;50(3):906–14. https://doi.org/10.1002/art.20200.
Kanaan SB, Sensoy O, Yan Z, Gadi VK, Richardson ML, Nelson JL. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism. Proc Natl Acad Sci. 2019:201904779. https://doi.org/10.1073/pnas.1904779116.
Guthrie KA, et al. Statistical methods for unusual count data: examples from studies of microchimerism. Am J Epidemiol. 2016;184(10):779–86. https://doi.org/10.1093/aje/kww093.
Kinder JM, et al. Cross-generational reproductive fitness enforced by microchimeric maternal cells. Cell. 2015;162(3):505–15. https://doi.org/10.1016/j.cell.2015.07.006.
Kinder JM, Stelzer IA, Arck PC, Way SS. Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol. 2017;17(8):483–94. https://doi.org/10.1038/nri.2017.38.
Harrington WE, et al. Maternal microchimerism predicts increased infection but decreased disease due to Plasmodium falciparum during early childhood. J Infect Dis. 2017;215(9):1445–51. https://doi.org/10.1093/infdis/jix129.
Stelzer IA, et al. Vertically transferred maternal immune cells promote neonatal immunity against early life infections. Nat Commun. 2021;12(1):4706. https://doi.org/10.1038/s41467-021-24719-z.
Czernek L, Düchler M. Exosomes as messengers between mother and fetus in pregnancy. Int J Mol Sci. 2020;21(12):E4264. https://doi.org/10.3390/ijms21124264.
Funding
This work was supported by the National Institutes of Health (K08HD067221, K08HL150169, R01HL11737).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclaimer
Chimerocyte, Inc. had no role in funding this research, providing testing materials, or analyzing results.
Conflict of Interest
JLN and SBK have ownership interests in Chimerocyte, Inc., for which highly sensitive and specific detection of allogeneic cells/DNA is its core technology. The remaining authors declare no competing financial interests.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shree, R., McCartney, S., Cousin, E. et al. Umbilical Cord Maternal Microchimerism in Normal and Preeclampsia Pregnancies. Reprod. Sci. 30, 1157–1164 (2023). https://doi.org/10.1007/s43032-022-01080-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-022-01080-0